Caribou Biosciences, Inc. (CRBU)
0.4487
+0.04
(+8.83%)
USD |
NASDAQ |
Nov 06, 16:00
0.4423
-0.01
(-1.43%)
After-Hours: 20:00
Caribou Biosciences Max Drawdown (5Y) : 98.18% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 98.18% |
| September 30, 2026 | 97.58% |
| August 31, 2026 | 97.58% |
| July 31, 2026 | 97.58% |
| June 30, 2026 | 97.58% |
| May 31, 2026 | 97.58% |
| April 30, 2026 | 97.58% |
| March 31, 2026 | 97.58% |
| Date | Value |
|---|---|
| February 28, 2026 | 97.58% |
| January 31, 2026 | 97.58% |
| December 31, 2025 | 97.58% |
| November 30, 2025 | 97.58% |
| October 31, 2025 | 97.58% |
| September 30, 2025 | 97.58% |
| August 31, 2025 | 97.58% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Anavex Life Sciences Corp. | 94.89% |
| Vaxcyte, Inc. | 76.22% |
| Foghorn Therapeutics, Inc. | 91.91% |
| Bolt Biotherapeutics, Inc. | 99.51% |
| Connect Biopharma Holdings Ltd. | 98.07% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -79.08 |
| Beta (5Y) | 2.504 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 87.47% |
| Historical Sharpe Ratio (5Y) | -0.6691 |
| Historical Sortino (5Y) | -1.362 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.24% |